Jefferies Financial Group Reiterates “Hold” Rating for Abbott Laboratories (NYSE:ABT)

Jefferies Financial Group reiterated their hold rating on shares of Abbott Laboratories (NYSE:ABT – Free Report) in a report issued on Thursday morning, Benzinga reports. Jefferies Financial Group currently has a $120.00 price objective on the healthcare product maker’s stock. Several other brokerages have also recently weighed in on ABT. The Goldman Sachs Group began […]

Leave a Reply

Your email address will not be published.

Previous post Analyzing Zuora (NYSE:ZUO) and Klaviyo (NYSE:KVYO)
Next post Easterly Government Properties (NYSE:DEA) Downgraded by StockNews.com to “Sell”